Supriya Lifescience (NSE:SUPRIYA) FCF Margin %: 0.00% (As of Mar. 2026)


NSE:SUPRIYA Supriya Lifescience Ltd NSE:SUPRIYA
76 GF Score
Price ₹970.75
GF Value ₹805.85
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Supriya Lifescience FCF Margin %?

Supriya Lifescience NSE:SUPRIYA +4.59% 76 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:SUPRIYA with a GF Score™ of 76/100 and a GF Value™ of ₹805.85 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 957 Biotechnology companies, Supriya Lifescience ranks better than 77.64% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Supriya Lifescience's Free Cash Flow for the three months ended in Mar. 2026 was ₹0 Mil. Supriya Lifescience's Revenue for the three months ended in Mar. 2026 was ₹2,765 Mil. Therefore, Supriya Lifescience's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Supriya Lifescience's current FCF Yield % is 0.43%.

The historical rank and industry rank for Supriya Lifescience's FCF Margin % or its related term are showing as below:

NSE:SUPRIYA' s FCF Margin % Range Over the Past 10 Years
Min: -9.82   Med: 2.19   Max: 29.37
Current: 4.05

During the past 8 years, the highest FCF Margin % of Supriya Lifescience was 29.37%. The lowest was -9.82%. And the median was 2.19%.

NSE:SUPRIYA's FCF Margin % is ranked better than
77.64% of 957 companies
in the Biotechnology industry
Industry Median: -84.65 vs NSE:SUPRIYA: 4.05

Supriya Lifescience FCF Margin % Related Terms

Supriya Lifescience FCF Margin % Historical Data

* Premium members only.

The historical data trend for Supriya Lifescience's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supriya Lifescience FCF Margin % Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial -2.14 -9.82 -5.80 0.33 4.05

Supriya Lifescience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:SUPRIYA vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Supriya Lifescience's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Supriya Lifescience FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's FCF Margin % falls into.


NSE:SUPRIYA
76GF Score
Supriya Lifescience Ltd NSE:SUPRIYA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supriya Lifescience FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Supriya Lifescience's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=335.34/8278.75
=4.05 %

Supriya Lifescience's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/2765.28
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Supriya Lifescience (NSE:SUPRIYA) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Supriya Lifescience and its competitors. According to the industry distribution chart, Supriya Lifescience ranks #214 out of 957 companies in the Biotechnology industry, placing it in the top 22.4%.
Is Supriya Lifescience's FCF Margin % too high?
Supriya Lifescience's current FCF Margin % is 0.00%. Based on the distribution chart, Supriya Lifescience ranks #214 out of 957 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Supriya Lifescience has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Supriya Lifescience's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Supriya Lifescience ranks #214 out of 957 companies for FCF Margin %. This places Supriya Lifescience in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Supriya Lifescience and its competitors. Supriya Lifescience's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supriya Lifescience stock overvalued right now?
Based on GuruFocus' analysis, Supriya Lifescience (NSE:SUPRIYA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹805.85, compared to a current price of ₹970.75 — trading 20.5% above its estimated fair value. The current FCF Margin % is 0.00%. Supriya Lifescience's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Supriya Lifescience (NSE:SUPRIYA), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supriya Lifescience (NSE:SUPRIYA) Overvalued in 2026?

Based on GuruFocus' analysis, Supriya Lifescience stock appears to be overvalued. The current stock price of ₹970.75 is trading 20.5% above its estimated GF Value™ of ₹805.85. GuruFocus considers Supriya Lifescience to be Modestly Overvalued.

Key valuation signals for NSE:SUPRIYA:

  • FCF Margin %: 0.00%
  • GF Value™: ₹805.85 vs. price of ₹970.75 (20.5% above fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the NSE:SUPRIYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Supriya Lifescience Business Description

Other Exchanges 543434:India
Address Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.
76GF Score

Get the complete analysis for NSE:SUPRIYA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹970.75
Price
₹805.85
GF Value